ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Sao Paulo Turismo Sa

Sao Paulo Turismo Sa (AHEB5)

45.00
0.00
(0.00%)
Closed 07 February 7:55AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
45.00
Bid
0.00
Offer
0.00
Volume
-
0.00 Day's Range 0.00
19.20 52 Week Range 45.00
Market Cap
Previous Close
45.00
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
220
Shares Outstanding
45,022
Dividend Yield
-
PE Ratio
0.02
Earnings Per Share (EPS)
1.91k
Revenue
610.42M
Net Profit
85.93M

About Sao Paulo Turismo Sa

Sector
Business Services, Nec
Industry
Business Services, Nec
Website
Headquarters
Sao Paulo, Sao Paulo, Bra
Founded
-
Sao Paulo Turismo Sa is listed in the Business Services sector of the Brazil Bovespa Exchange with ticker AHEB5. The last closing price for SP TURISMO PNA was R$45. Over the last year, SP TURISMO PNA shares have traded in a share price range of R$ 19.20 to R$ 45.00.

SP TURISMO PNA currently has 45,022 shares in issue. The market capitalisation of SP TURISMO PNA is R$2.03 million. SP TURISMO PNA has a price to earnings ratio (PE ratio) of 0.02.

AHEB5 Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000PR
40000000PR
120045454522045PR
261028.571428571435453522940.7859375PR
5225.79134.25299323319.214519.222437.37815789PR
15623104.545454545224516.4919129.90770492PR
26021.4991.40791152723.514516.4920025.50975806PR

AHEB5 - Frequently Asked Questions (FAQ)

What is the current SP TURISMO PNA share price?
The current share price of SP TURISMO PNA is R$ 45.00
How many SP TURISMO PNA shares are in issue?
SP TURISMO PNA has 45,022 shares in issue
What is the market cap of SP TURISMO PNA?
The market capitalisation of SP TURISMO PNA is BRL 2.03M
What is the 1 year trading range for SP TURISMO PNA share price?
SP TURISMO PNA has traded in the range of R$ 19.20 to R$ 45.00 during the past year
What is the PE ratio of SP TURISMO PNA?
The price to earnings ratio of SP TURISMO PNA is 0.02
What is the cash to sales ratio of SP TURISMO PNA?
The cash to sales ratio of SP TURISMO PNA is 0
What is the reporting currency for SP TURISMO PNA?
SP TURISMO PNA reports financial results in BRL
What is the latest annual turnover for SP TURISMO PNA?
The latest annual turnover of SP TURISMO PNA is BRL 610.42M
What is the latest annual profit for SP TURISMO PNA?
The latest annual profit of SP TURISMO PNA is BRL 85.93M
What is the registered address of SP TURISMO PNA?
The registered address for SP TURISMO PNA is AV. OLAVO FONTOURA, 1209, ANHEMBI PARQUE, SANTANA - SAO PAUL, SAO PAULO, SAO PAULO, 02012-021
What is the SP TURISMO PNA website address?
The website address for SP TURISMO PNA is spturis.com/v7
Which industry sector does SP TURISMO PNA operate in?
SP TURISMO PNA operates in the BUSINESS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABCB4Banco ABC Brasil S.A.
R$ 21.10
(0.00%)
0
AALR3RAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3QAllianca Saude e Participacoes S.A.
R$ 14.95
(0.00%)
0
AALR3MAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3Allianca Saude e Participacoes S.A.
R$ 10.31
(0.00%)
0
ABCB4Banco ABC Brasil S.A.
R$ 21.10
(0.00%)
0
AALR3RAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3QAllianca Saude e Participacoes S.A.
R$ 14.95
(0.00%)
0
AALR3MAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3Allianca Saude e Participacoes S.A.
R$ 10.31
(0.00%)
0
ABCB4Banco ABC Brasil S.A.
R$ 21.10
(0.00%)
0
AALR3RAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3QAllianca Saude e Participacoes S.A.
R$ 14.95
(0.00%)
0
AALR3MAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3Allianca Saude e Participacoes S.A.
R$ 10.31
(0.00%)
0

Discussion

View Full Feed
JSmith5 JSmith5 1 minute ago
HUD's Turner only puts the word Congress in his mouth to facilitate Pulte's confirmation. The release process will be done administratively.

Completely agree - And I am sure that Pulte say that he will "consult with congress" about 50 times during his hearing.

Nats
FNMA
Mark Mark 1 minute ago
$EQ .99 on watch
EQ
glenn1919 glenn1919 1 minute ago
EQ.....................MULN....................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
MULN
oystersnbeer oystersnbeer 2 minutes ago
By Maga standards ,
You’re a Genius!
BlazingStocks BlazingStocks 2 minutes ago
$BURU - Nuburu’s AO Series are covered by one or more of the following Untied States and foreign patents and patent applications
https://www.nuburu.net/patents/
BURU
glenn1919 glenn1919 3 minutes ago
EQ................................https://stockcharts.com/h-sc/ui?s=EQ&p=W&b=5&g=0&id=p86431144783
EQ
georgie18 georgie18 3 minutes ago
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
ALLR
mike_dotcom mike_dotcom 3 minutes ago
Another week of nothing except a declining stock price.
AVXL
georgie18 georgie18 3 minutes ago
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
ALLR
chereb19 chereb19 3 minutes ago
The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t
RDGL
georgie18 georgie18 3 minutes ago
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
ALLR
TheDane TheDane 3 minutes ago
SMCI announced a business update for Feb. 11. They released news about “ramping up” at one the AI data center. These two items are positive for the company and shareholders so why wouldn’t that be the more obvious reason for the rise in share price? Especially since it dropped significantly the week
SMCI
Here Today Here Today 3 minutes ago
News is Out!!!!!
RNAZ
georgie18 georgie18 3 minutes ago
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
ALLR
subslover subslover 4 minutes ago
😁CONGRATS!😷
LIPO
chereb19 chereb19 4 minutes ago
Fantasy products made up by you don't really exist.

Why don't you site the clinical trials here

https://trialsearch.who.int/

If you can't , they don't exist
RDGL
royal1 royal1 4 minutes ago
I made my money following the bashers and i am sure that i am not the only one.
HMBL
Mark Mark 4 minutes ago
$RLMD .46
RLMD
Mark Mark 4 minutes ago
$RLMD .46
RLMD
Dallas-Cowboys Dallas-Cowboys 5 minutes ago
Huh you find that strange that he is dealing with the deaths of 74 people and a Learjet accident where the cause could effect every Learjet out there. I find your post strange
TGLO
Magnum7419 Magnum7419 5 minutes ago
how does one have zero followers /?
AHRO
sharkey1 sharkey1 5 minutes ago
Its always the day after they release financials after hours.
ELTP
Trooperstocks Trooperstocks 7 minutes ago
NEWS: $ZENA ZenaTech’s ZenaDrone Starts Testing its High-Density Batteries to Extend Flight Time for ZenaDrone 1000 Drone for US Defense Applications

February 06, 2025 07:30 ET | Source: ZenaTech Inc.

VANCOUVER, British Columbia, Feb. 06, 2025 (GLOBE NEWSWIRE) -- ZenaT
ZENA
georgie18 georgie18 7 minutes ago
IMRX...$1.99...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021891/0/en/Immuneering-Announces-Clinical-Supply-Agreement-with-Regeneron-Pharmaceuticals-to-Evaluate-IMM-1-104-in-Combination-with-Libtayo-cemiplimab.html
IMRX
Trooperstocks Trooperstocks 7 minutes ago
$ZENA $4.89 +4.94% on pre-market news!
ZENA

Your Recent History

Delayed Upgrade Clock